These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20449668)

  • 1. Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.
    Lorenzen S; Panzram B; Keller G; Lordick F; Herrmann K; Becker K; Langer R; Schwaiger M; Siewert JR; Ott K
    Mol Imaging Biol; 2011 Feb; 13(1):178-86. PubMed ID: 20449668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    Lorenzen S; von Gall C; Stange A; Haag GM; Weitz J; Haberkorn U; Lordick F; Weichert W; Abel U; Debus J; Jäger D; Münter MW
    BMC Cancer; 2011 Jun; 11():266. PubMed ID: 21702914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
    Wolf G; Aigner RM; Schaffler G; Langsenlehner U; Renner W; Samonigg H; Yazdani-Biuki B; Krippl P
    Breast Cancer Res Treat; 2004 Dec; 88(3):205-8. PubMed ID: 15609122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
    zum Büschenfelde CM; Herrmann K; Schuster T; Geinitz H; Langer R; Becker K; Ott K; Ebert M; Zimmermann F; Friess H; Schwaiger M; Peschel C; Lordick F; Krause BJ
    J Nucl Med; 2011 Aug; 52(8):1189-96. PubMed ID: 21764790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
    Lordick F; Ott K; Krause BJ; Weber WA; Becker K; Stein HJ; Lorenzen S; Schuster T; Wieder H; Herrmann K; Bredenkamp R; Höfler H; Fink U; Peschel C; Schwaiger M; Siewert JR
    Lancet Oncol; 2007 Sep; 8(9):797-805. PubMed ID: 17693134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
    Weber MA; Bender K; von Gall CC; Stange A; Grünberg K; Ott K; Haberkorn U; Kauczor HU; Zechmann C
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):45-52. PubMed ID: 23539390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
    Kim SJ; Hwang SH; Kim IJ; Lee MK; Lee CH; Lee SY; Lee EY
    J Exp Clin Cancer Res; 2010 Jun; 29(1):69. PubMed ID: 20540786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing neoadjuvant chemotherapy through the use of early response evaluation by positron emission tomography.
    Lordick F
    Recent Results Cancer Res; 2012; 196():201-11. PubMed ID: 23129376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer.
    Bae SJ; Ahn DH; Hong SP; Kang H; Hwang SG; Oh D; Kim NK
    Yonsei Med J; 2008 Oct; 49(5):783-91. PubMed ID: 18972599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene and risk of esophageal cancer in the Kashmiri population.
    Qasim I; Bhat IA; Masoodi KZ; Shah ZA
    Asian Pac J Cancer Prev; 2015; 16(1):97-101. PubMed ID: 25640399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
    Etienne-Grimaldi MC; Formento P; Degeorges A; Pierga JY; Delva R; Pivot X; Dalenc F; Espié M; Veyret C; Formento JL; Francoual M; Piutti M; de Crémoux P; Milano G
    Br J Clin Pharmacol; 2011 Jun; 71(6):921-8. PubMed ID: 21204912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
    Bradbury PA; Zhai R; Ma C; Xu W; Hopkins J; Kulke MJ; Asomaning K; Wang Z; Su L; Heist RS; Lynch TJ; Wain JC; Christiani D; Liu G
    Clin Cancer Res; 2009 Jul; 15(14):4680-5. PubMed ID: 19584152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative EOX treatment in operable locally advanced gastroesophageal adenocarcinoma: Prediction of tumor response by FDG -PET and histopathology.
    Vihervaara H; Ålgars A; Kemppainen J; Sundström J; Ristamäki R; Salminen P
    Surg Oncol; 2019 Mar; 28():42-49. PubMed ID: 30851910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Harustiak T; Zemanova M; Fencl P; Hornofova L; Pazdro A; Snajdauf M; Salkova E; Lischke R; Stolz A
    Br J Surg; 2018 Mar; 105(4):419-428. PubMed ID: 29417984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of mid-radiotherapy
    Kim N; Cho H; Yun M; Park KR; Lee CG
    Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor +936C/T polymorphism and cancer risk in Asians: a meta-analysis.
    Liu XL; Yang QF; Kong BH
    Genet Mol Res; 2013 Jun; 12(2):1924-33. PubMed ID: 23913375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
    Ott K; Weber WA; Lordick F; Becker K; Busch R; Herrmann K; Wieder H; Fink U; Schwaiger M; Siewert JR
    J Clin Oncol; 2006 Oct; 24(29):4692-8. PubMed ID: 16966684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of
    Arnett ALH; Merrell KW; Macintosh EM; James SE; Nathan MA; Shen KR; Ravi K; Neben Wittich MA; Haddock MG; Hallemeier CL
    J Thorac Oncol; 2017 Jan; 12(1):121-128. PubMed ID: 27569732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene with sporadic breast cancer in North Indians.
    Kapahi R; Manjari M; Sudan M; Uppal MS; Singh NR; Sambyal V; Guleria K
    Asian Pac J Cancer Prev; 2014; 15(1):257-63. PubMed ID: 24528036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.